Figo stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973‐87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina
- 1 January 1994
- journal article
- review article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 10 (1) , 31-46
- https://doi.org/10.1002/ssu.2980100107
Abstract
The prognostic impact of FIGO stage, histology, histologic grade, age and race in survival for cancers of the female gynecological (cervix, endometrium, ovary, vulva, vagina) were examined using cases obtained from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program that were diagnosed between 1973 and 1987. Utilizing Cox proportional hazards modeling and relative survival rates analysis of 17,119 cases of cervical cancer indicated that the International Federation of Gynecology and Obstetrics (FIGO) stage, histology, histological grade, lymph node status, and age at diagnosis were all independently prognostic. No evidence was found of survival differences between squamous cell carcinoma and adenocarcinoma. Younger women were not found to have a poorer prognosis, survival declined with increased age. Analysis of 41,120 cases of endometrial cancer indicated that FIGO stage, histology, histologic grade, lymph node status, age at diagnostic, and race were all prognostic factors. Clear cell adenocarcinoma, leiomyosarcoma, and mixed mullerian tumors were all found to have poorer prognosis. Analysis of 21,240 cases of ovarian cancer indicated that FIGO stage, histology, histologic grade, lymph node status, age at diagnosis, presence of ascites, and race were all prognostically significant. Analysis of 2,575 cases of vulvar cancer indicated that FIGO stage, histology, histologic grade, age, and race were all prognostically significant. Analysis of 916 cases of vaginal cancer indicated that FIGO stage, histologic grade, lymph node status, and age are all prognostically significant. Additional analysis of the data by combinations of independent prognostic factors indicates that the interaction of factors may be more predictive of outcome than any one factor separately. © 1994 Wiley‐Liss, Inc.†Keywords
This publication has 66 references indexed in Scilit:
- Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcomaBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: A population-based epidemiologic studyAmerican Journal of Obstetrics and Gynecology, 1992
- Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (A Gynecologic Oncology Group Study)American Journal of Obstetrics and Gynecology, 1991
- Invasive squamous cell carcinoma of the cervix in women less than 35 years old: Recurrent versus nonrecurrent diseaseAmerican Journal of Obstetrics and Gynecology, 1988
- Cervical carcinoma in women aged 34 and youngerAmerican Journal of Obstetrics and Gynecology, 1986
- Invasive cervical cancer in young womenBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariable analysis of the effect of age, stage, histology and blood counts on survivalInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Histologic correlates of virulence in ovarian adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1982
- Prognostic Significance of Age in Stage I Carcinoma or the CervixSouthern Medical Journal, 1980
- Mixed Adenosquamous Carcinoma of the EndometriumAmerican Journal of Clinical Pathology, 1973